Intuitive Surgical Inc

Find Ratings Reports
ISRG : NASDAQ : Health Care
$1045.47 -0.82 | -0.08%
Today's Range: 1040.63 - 1053.0
Avg. Daily Volume: 332500.0
09/19/17 - 4:00 PM ET

Financial Analysis


INTUITIVE SURGICAL INC's gross profit margin for the second quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. INTUITIVE SURGICAL INC is extremely liquid. Currently, the Quick Ratio is 3.90 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

During the same period, stockholders' equity ("net worth") has decreased by 12.72% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)756.2670.1
EBITDA ($mil)0.00.0
EBIT ($mil)257.5249.8
Net Income ($mil)221.5184.5


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)1823.42183.8
Total Assets ($mil)5250.85780.8
Total Debt ($mil)0.00.0
Equity ($mil)4522.35181.5


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin69.8170.27
EBITDA Margin0.00.0
Operating Margin34.0537.28
Sales Turnover0.550.44
Return on Assets15.5411.73
Return on Equity18.0513.08
Debt Q2 FY17 Q2 FY16
Current Ratio4.415.78
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)37.138.5
Div / share0.00.0
EPS5.774.71
Book value / share121.89134.58
Institutional Own % n/a n/a
Avg Daily Volume337873.0321022.0

Valuation


BUY. This stock's P/E ratio indicates a premium compared to an average of 48.70 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 24.88. For additional comparison, its price-to-book ratio of 8.54 indicates a significant premium versus the S&P 500 average of 3.10 and a significant premium versus the industry average of 4.90. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, INTUITIVE SURGICAL INC proves to trade at a premium to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ISRG 49.83 Peers 48.70   ISRG 38.08 Peers 37.09

Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.

ISRG is trading at a valuation on par with its peers.

 

Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ISRG is trading at a valuation on par to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ISRG 37.41 Peers 33.41   ISRG 1.87 Peers 1.03

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

ISRG is trading at a significant premium to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ISRG trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ISRG 8.54 Peers 4.90   ISRG 18.36 Peers 47.56

Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ISRG is trading at a significant premium to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, ISRG is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ISRG 13.45 Peers 5.32   ISRG 13.41 Peers 15.38

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ISRG is trading at a significant premium to its industry.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ISRG trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades